Integrated Wealth Counsel’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$324K Sell
5,175
-19
-0.4% -$1.16K 0.7% 25
2016
Q3
$328K Buy
5,194
+314
+6% +$20.3K 0.69% 23
2016
Q2
$302K Hold
4,880
0.69% 17
2016
Q1
$279K Sell
4,880
-4,880
-50% -$272K 0.64% 17
2015
Q4
$555K Buy
9,760
+4,880
+100% +$281K 0.89% 14
2015
Q3
$266K Hold
4,880
0.45% 15
2015
Q2
$328K Hold
4,880
0.46% 16
2015
Q1
$286K Hold
4,880
0.36% 19
2014
Q4
$319K Hold
4,880
0.38% 18
2014
Q3
$282K Hold
4,880
0.29% 20
2014
Q2
$275K Sell
4,880
-437
-8% -$22.9K 0.22% 33
2014
Q1
$273K Hold
5,317
0.22% 50
2013
Q4
$281K Buy
5,317
+400
+8% +$19.7K 0.21% 51
2013
Q3
$220K Buy
4,917
+37
+0.8% +$1.64K 0.16% 57
2013
Q2
$202K Buy
+4,880
New +$213K 0.15% 60

Other funds holding ABBV

Integrated Wealth Counsel's ABBV Position: Q4 2016 in Review

Integrated Wealth Counsel reduced its AbbVie (ABBV) stake by 0.37% in Q4 2016, selling an estimated $1.16K and leaving 5,175 shares worth $324K. The position accounts for 0.7% of the portfolio, ranked #25.

Integrated Wealth Counsel first reported a position in ABBV in Q2 2013 and has held it in 15 quarters since. The position peaked at $555K in Q4 2015. 1,692 funds tracked by Wall St. Rank hold ABBV as of Q4 2016.

  • Integrated Wealth Counsel held 5,175 shares of AbbVie worth $324K as of Q4 2016.
  • Integrated Wealth Counsel sold 19 AbbVie shares in Q4 2016, an estimated $1.16K.
  • AbbVie made up 0.7% of Integrated Wealth Counsel's portfolio in Q4 2016, its #25 holding.
  • Integrated Wealth Counsel first reported a position in AbbVie in Q2 2013 and has held it in 15 quarters since.
  • Integrated Wealth Counsel's AbbVie position peaked at $555K in Q4 2015.
  • 1,692 funds tracked by Wall St. Rank held AbbVie as of Q4 2016.

Based on Integrated Wealth Counsel's 13F filing for Q4 2016, filed 6 Feb 2017.